Mablink Bioscience
Lyon
About Mablink Bioscience
Mablink Bioscience is a biotechnology company specialized in the development of a new class of cancer drugs, called Antibody Drug Conjugate (ADC).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $35.0M
- Funding stage: M&A
- Last round: Series A (Oct 2022)
- Website: mablink.com
Industries & Categories
Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/mablink-bioscience-129779 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.